Northwestern Mutual Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$78.6K Sell
625
-368
-37% -$46.3K ﹤0.01% 2086
2025
Q1
$110K Sell
993
-260
-21% -$28.8K ﹤0.01% 1898
2024
Q4
$171K Buy
1,253
+116
+10% +$15.8K ﹤0.01% 1719
2024
Q3
$131K Buy
1,137
+380
+50% +$43.8K ﹤0.01% 1787
2024
Q2
$104K Buy
757
+50
+7% +$6.88K ﹤0.01% 1816
2024
Q1
$97.5K Buy
707
+6
+0.9% +$828 ﹤0.01% 1817
2023
Q4
$92.4K Buy
701
+367
+110% +$48.4K ﹤0.01% 1813
2023
Q3
$37.6K Sell
334
-52
-13% -$5.85K ﹤0.01% 2080
2023
Q2
$36.4K Sell
386
-39
-9% -$3.68K ﹤0.01% 2103
2023
Q1
$43K Sell
425
-145
-25% -$14.7K ﹤0.01% 1993
2022
Q4
$68.1K Sell
570
-2,383
-81% -$285K ﹤0.01% 1808
2022
Q3
$314K Sell
2,953
-45
-2% -$4.79K ﹤0.01% 1236
2022
Q2
$292K Buy
2,998
+64
+2% +$6.23K ﹤0.01% 1267
2022
Q1
$275K Sell
2,934
-94
-3% -$8.81K ﹤0.01% 1319
2021
Q4
$258K Buy
3,028
+98
+3% +$8.35K ﹤0.01% 1328
2021
Q3
$281K Buy
2,930
+50
+2% +$4.8K ﹤0.01% 1218
2021
Q2
$281K Sell
2,880
-1,222
-30% -$119K ﹤0.01% 1191
2021
Q1
$399K Buy
4,102
+2,913
+245% +$283K ﹤0.01% 998
2020
Q4
$114K Sell
1,189
-2,320
-66% -$222K ﹤0.01% 1358
2020
Q3
$337K Buy
3,509
+1,813
+107% +$174K ﹤0.01% 861
2020
Q2
$207K Buy
1,696
+1,617
+2,047% +$197K ﹤0.01% 958
2020
Q1
$7K Buy
79
+17
+27% +$1.51K ﹤0.01% 1991
2019
Q4
$7K Buy
62
+2
+3% +$226 ﹤0.01% 1998
2019
Q3
$5K Sell
60
-26
-30% -$2.17K ﹤0.01% 2101
2019
Q2
$7K Hold
86
﹤0.01% 2050
2019
Q1
$7K Sell
86
-174
-67% -$14.2K ﹤0.01% 2052
2018
Q4
$19K Buy
260
+164
+171% +$12K ﹤0.01% 1610
2018
Q3
$12K Hold
96
﹤0.01% 1873
2018
Q2
$9K Sell
96
-15
-14% -$1.41K ﹤0.01% 1864
2018
Q1
$9K Buy
111
+15
+16% +$1.22K ﹤0.01% 1784
2017
Q4
$7K Hold
96
﹤0.01% 1858
2017
Q3
$6K Hold
96
﹤0.01% 1783
2017
Q2
$4K Buy
+96
New +$4K ﹤0.01% 1782